BR9103550A - Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica - Google Patents

Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica

Info

Publication number: BR9103550A
Authority: BR; Brazil
Prior art keywords: pirazol; starch; manufacture; pharmaceutical composition; pharmaceutical
Prior art date: 1990-08-20

Application number

BR919103550A

Other languages

English (en)

Inventor

Robert Mboigegrain

Danielle Gully

Francis Jeanjean

Jean-Charles Molimard

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-20

Filing date

1991-08-19

Publication date

1992-04-07

1991-08-19 Application filed by Sanofi Sa filed Critical Sanofi Sa

1992-04-07 Publication of BR9103550A publication Critical patent/BR9103550A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

BR919103550A 1990-08-20 1991-08-19 Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica BR9103550A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9010486A FR2665898B1 (fr)	1990-08-20	1990-08-20	Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number	Publication Date
BR9103550A true BR9103550A (pt)	1992-04-07

Family

ID=9399742

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR919103550A BR9103550A (pt)	1990-08-20	1991-08-19	Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica

Country Status (31)

Country	Link
US (6)	US5420141A (pt)
EP (1)	EP0477049B1 (pt)
JP (1)	JP2694932B2 (pt)
KR (1)	KR100223074B1 (pt)
AR (1)	AR248133A1 (pt)
AT (1)	ATE187167T1 (pt)
AU (1)	AU646683B2 (pt)
BR (1)	BR9103550A (pt)
CA (4)	CA2166902C (pt)
CZ (1)	CZ281864B6 (pt)
DE (1)	DE69131813T2 (pt)
DK (1)	DK0477049T3 (pt)
ES (1)	ES2142798T3 (pt)
FI (1)	FI104170B (pt)
FR (1)	FR2665898B1 (pt)
GR (1)	GR3032732T3 (pt)
HU (2)	HU217435B (pt)
IE (1)	IE912932A1 (pt)
IL (1)	IL99225A (pt)
LT (1)	LT3520B (pt)
LV (1)	LV10434B (pt)
MX (1)	MX9203576A (pt)
MY (1)	MY121908A (pt)
NO (1)	NO300212B1 (pt)
NZ (1)	NZ239476A (pt)
PL (1)	PL169085B1 (pt)
PT (1)	PT98717B (pt)
RU (1)	RU2066317C1 (pt)
SG (1)	SG52322A1 (pt)
TW (1)	TW366337B (pt)
ZA (1)	ZA916583B (pt)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104311A (en) *	1992-02-05	1997-07-13	Fujisawa Pharmaceutical Co	Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713224B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0666851A4 (en) *	1992-11-02	1995-08-30	Merck & Co. Inc.	Substituted phthalazinones as nerotensin antagonists.
FR2711140B1 (fr) *	1993-10-12	1996-01-05	Sanofi Sa	1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
US6492411B1 (en)	1993-11-30	2002-12-10	G. D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5466823A (en) *	1993-11-30	1995-11-14	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides
US6716991B1 (en)	1993-11-30	2004-04-06	G. D. Searle & Co.	Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
CA2276946A1 (en) *	1993-11-30	1995-06-08	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions containing the same
FR2714057B1 (fr) *	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2722193B1 (fr) *	1994-07-08	1996-10-04	Sanofi Sa	Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant
FR2732967B1 (fr) *	1995-04-11	1997-07-04	Sanofi Sa	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
US5756529A (en) *	1995-09-29	1998-05-26	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
FR2741621B1 (fr) *	1995-11-23	1998-02-13	Sanofi Sa	Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2742148B1 (fr) *	1995-12-08	1999-10-22	Sanofi Sa	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA9711102B (en) *	1996-12-16	1998-08-13	Yamanouchi Pharma Co Ltd	N-[(substituted 5-membered heteroaryl)carbonyl] guanidine derivative
US5776987A (en) *	1997-03-03	1998-07-07	Sanofi Pharmaceuticals, Inc.	Pharmaceutical suspension formulation
US5760056A (en) *	1997-03-03	1998-06-02	Sanofi Pharmaceuticals, Inc.	Pharmaceutical formulation
US5837714A (en) *	1997-03-03	1998-11-17	Sanofi	Solid pharmaceutical dispersions
US6197787B1 (en)	1997-03-03	2001-03-06	Sanofi-Synthelabo	Pharmaceutical formulations containing poorly soluble drug substances
ATE300293T1 (de) *	1997-03-03	2005-08-15	Sanofi Aventis	Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
JP2002504909A (ja)	1997-06-13	2002-02-12	スミスクライン・ビーチャム・コーポレイション	新規な置換ピラゾールおよびピラゾリン化合物
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
JP2001526230A (ja)	1997-12-19	2001-12-18	スミスクライン・ビーチャム・コーポレイション	ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
WO2000010563A1 (en) *	1998-08-20	2000-03-02	Smithkline Beecham Corporation	Novel substituted triazole compounds
ATE258055T1 (de)	1998-11-04	2004-02-15	Smithkline Beecham Corp	Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
US6191147B1 (en) *	1998-12-24	2001-02-20	Ppd Discovery, Inc.	Pyrazole compounds and uses thereof
FR2800375B1 (fr) *	1999-11-03	2004-07-23	Sanofi Synthelabo	Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
FR2800372B1 (fr) *	1999-11-03	2001-12-07	Sanofi Synthelabo	Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
EP1233950B1 (en)	1999-11-23	2005-10-05	Smithkline Beecham Corporation	3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
US6759410B1 (en) *	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
DE60015599T2 (de)	1999-11-23	2005-11-03	Smithkline Beecham Corp.	3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
AU6469401A (en)	2000-05-19	2001-11-26	Serono Reproductive Biology In	Pharmaceutically active compounds and methods of use
AU2002246855B2 (en)	2000-10-23	2005-12-22	Smithkline Beecham Corporation	Novel compounds
AU2002341729A1 (en)	2001-09-19	2003-04-01	Pharmacia Corporation	Substituted pyrazolyl compounds for the treatment of inflammation
US6849653B2 (en)	2001-09-19	2005-02-01	Pharmacia Corporation	Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
DE10146867A1 (de) *	2001-09-24	2003-04-24	Bayer Ag	Tetrahydroisochinoline
ATE372114T1 (de) *	2001-09-27	2007-09-15	Applied Research Systems	Verfahren zur erhöhung des testosteronspiegels
AR038967A1 (es) *	2002-03-18	2005-02-02	Solvay Pharm Bv	Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina
US20050004122A1 (en) *	2002-08-14	2005-01-06	Brown Bradley B.	Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use
EP1534680B1 (en) *	2002-08-14	2012-02-22	Pharmaco Investments, Inc.	Prenylation inhibitors and methods of their synthesis and use
US6649638B1 (en)	2002-08-14	2003-11-18	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
EP1556373A1 (en) *	2002-10-18	2005-07-27	Pfizer Products Inc.	Cannabinoid receptor ligands and uses thereof
US7129239B2 (en) *	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en) *	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US7429581B2 (en) *	2002-12-23	2008-09-30	Sanofi-Aventis Deutschland Gmbh	Pyrazole-derivatives as factor Xa inhibitors
EP1433788A1 (en) *	2002-12-23	2004-06-30	Aventis Pharma Deutschland GmbH	Pyrazole-derivatives as factor Xa inhibitors
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
EP1591443B1 (en) *	2003-02-07	2010-08-25	Daiichi Sankyo Company, Limited	Pyrazole derivative
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en)	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) *	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US20040214856A1 (en) *	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
CA2524397A1 (en) *	2003-05-07	2004-11-18	Pfizer Products Inc.	Cannabinoid receptor ligands and uses thereof
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US20040259887A1 (en) *	2003-06-18	2004-12-23	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
EP2256106B1 (en)	2003-07-22	2015-05-06	Astex Therapeutics Limited	3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
EP1670460B1 (en) *	2003-10-10	2014-11-26	Bristol-Myers Squibb Company	Pyrazole derivatives as cannabinoid receptor modulators
TW200526641A (en) *	2003-12-26	2005-08-16	Daiichi Seiyaku Co	Amidopyrazole derivatives
EP1718617B1 (en) *	2004-02-20	2009-08-19	AstraZeneca AB	3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
ITMI20041032A1 (it)	2004-05-24	2004-08-24	Neuroscienze S C A R L	Compositi farmaceutici
WO2006004027A1 (ja) *	2004-07-01	2006-01-12	Daiichi Pharmaceutical Co., Ltd.	ピラゾール誘導体
US20080146614A1 (en) *	2004-12-23	2008-06-19	Leifeng Cheng	Therapeutic Agents
US8404718B2 (en)	2005-01-21	2013-03-26	Astex Therapeutics Limited	Combinations of pyrazole kinase inhibitors
RU2425677C2 (ru) *	2005-01-21	2011-08-10	Астекс Терапьютикс Лимитед	Соединения, предназначенные для использования в фармацевтике
TWI389690B (zh)	2005-03-25	2013-03-21	Glaxo Group Ltd	新穎化合物（一）
US7923465B2 (en)	2005-06-02	2011-04-12	Glenmark Pharmaceuticals S.A.	Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
WO2006133926A1 (en) *	2005-06-17	2006-12-21	Carex Sa	Pyrazole derivates as cannabinoid receptor modulators
GB0514738D0 (en) *	2005-07-19	2005-08-24	Astrazeneca Ab	Therapeutic agents
AU2007226673A1 (en) *	2006-03-10	2007-09-20	Jenrin Discovery	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
JP2009543771A (ja) *	2006-07-14	2009-12-10	アステックス・セラピューティクス・リミテッド	医薬化合物
GB0619611D0 (en) *	2006-10-04	2006-11-15	Ark Therapeutics Ltd	Compounds and their use
JP5222855B2 (ja) *	2006-12-18	2013-06-26	７ティーエムファーマエイ／エス	Ｃｂ１受容体のモジュレーター
US7977358B2 (en) *	2007-07-26	2011-07-12	Hoffmann-La Roche Inc.	Pyrazol derivatives
US7943653B2 (en) *	2007-08-13	2011-05-17	Janssen Pharmaceutica N.V.	Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
US8133904B2 (en) *	2007-09-07	2012-03-13	Jenrin Discovery, Inc.	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
WO2009051772A1 (en) *	2007-10-17	2009-04-23	Duke University	Geranylgeranyl transferase inhibitors and methods of making and using the same
KR100917037B1 (ko) *	2007-11-01	2009-09-10	한국과학기술연구원	피라졸릴카르복스아미도알킬피페라진 유도체 및 이의제조방법
DE102009036604A1 (de)	2009-07-30	2011-02-03	Aicuris Gmbh & Co. Kg	Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
WO2011156557A2 (en) *	2010-06-11	2011-12-15	Thomas James B	Compounds active at the neurotensin receptor
CN102250006B (zh) *	2011-05-12	2014-03-05	范如霖	3-吡唑羧酸酰胺类化合物、其制备方法及其在制备作为cb1受体抑制剂药物中的应用
EP2740726A1 (en)	2012-12-07	2014-06-11	3B Pharmaceuticals GmbH	Neurotensin receptor ligands
WO2015148465A1 (en) *	2014-03-25	2015-10-01	Research Triangle Institute	Pyrazole compounds selective for neurotensin 2 receptor
WO2015188073A1 (en) *	2014-06-06	2015-12-10	Research Triangle Institute	Apelin receptor (apj) agonists and uses thereof
BR112018011784A2 (pt) *	2015-12-09	2018-12-04	Res Triangle Inst	agonistas aprimorados do receptor de apelina (apj) e usos dos mesmos
EP3279197A1 (en) *	2016-08-03	2018-02-07	Friedrich-Alexander-Universität Erlangen-Nürnberg	Diagnosis, treatment and prevention of neurotensin receptor-related conditions
TWI805699B (zh)	2018-03-01	2023-06-21	日商日本煙草產業股份有限公司	甲基內醯胺環化合物及其用途
SG11202009179TA (en)	2018-04-04	2020-10-29	Japan Tobacco Inc	Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof
JP2022545698A (ja) *	2019-08-29	2022-10-28	リサーチトライアングルインスティテュート	アペリン受容体アゴニストのための方法および使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4134987A (en) *	1976-01-14	1979-01-16	Huppatz John L	Compounds and compositions
ES513398A0 (es) *	1981-06-26	1983-03-01	Warner Lambert Co	"un procedimiento para preparar derivados de dialcohilpirazol".
US4495195A (en) *	1982-11-01	1985-01-22	Eli Lilly And Company	Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
DE3332633A1 (de) *	1983-09-09	1985-04-04	Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München	Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
IL73419A (en) *	1983-11-07	1988-02-29	Lilly Co Eli	1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them
JPS611651A (ja) *	1984-06-12	1986-01-07	Toyama Chem Co Ltd	Ｎ−アシル酸性アミノ酸ジアミド類およびその製造法並びにそれらを含有する抗潰瘍剤
WO1986002641A1 (fr) *	1984-10-29	1986-05-09	Sumitomo Chemical Company, Limited	Derives de pyrazolecarboxamide, procede de preparation et bactericides les contenant en tant qu'ingredients efficaces
JPH0678342B2 (ja) *	1986-01-07	1994-10-05	三共株式会社	新規マクロライド化合物
US4792565A (en) *	1986-04-24	1988-12-20	Mitsui Toatsu Chemicals, Inc.	Pyrazolecarbonylamine derivatives and agricultural and horticultural fungicides containing said compounds
US4826868A (en) *	1986-05-29	1989-05-02	Ortho Pharmaceutical Corporation	1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US4954506A (en) *	1987-02-02	1990-09-04	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US4791112A (en) *	1987-02-02	1988-12-13	The Boc Group, Inc.	N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US4916142A (en) *	1987-02-02	1990-04-10	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and their use as analgesics
US4912109A (en) *	1987-02-02	1990-03-27	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
JPS6425763A (en) *	1987-04-24	1989-01-27	Mitsubishi Chem Ind	Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
US4971978A (en) *	1987-09-21	1990-11-20	Nadzan Alex M	Derivatives of D-glutamic acid and D-aspartic acid
AU2793389A (en) *	1987-11-30	1989-07-05	E.I. Du Pont De Nemours And Company	Heterocyclic pyrazoline carboxanilides
JP2861104B2 (ja) *	1988-10-14	1999-02-24	三菱化学株式会社	ピラゾールアミド類およびこれを有効成分とする殺虫、殺ダニ剤
WO1990014347A1 (fr) *	1989-05-24	1990-11-29	Nippon Shinyaku Co., Ltd.	Derives d'indole et medicament

1990
- 1990-08-20 FR FR9010486A patent/FR2665898B1/fr not_active Expired - Fee Related
1991
- 1991-08-17 HU HU750/91A patent/HU217435B/hu unknown
- 1991-08-19 AR AR91320430A patent/AR248133A1/es active
- 1991-08-19 NO NO913234A patent/NO300212B1/no unknown
- 1991-08-19 IE IE293291A patent/IE912932A1/en not_active IP Right Cessation
- 1991-08-19 TW TW080106546A patent/TW366337B/zh not_active IP Right Cessation
- 1991-08-19 IL IL9922591A patent/IL99225A/en not_active IP Right Cessation
- 1991-08-19 FI FI913917A patent/FI104170B/fi active
- 1991-08-19 PL PL91291463A patent/PL169085B1/pl not_active IP Right Cessation
- 1991-08-19 BR BR919103550A patent/BR9103550A/pt not_active Application Discontinuation
- 1991-08-19 PT PT98717A patent/PT98717B/pt not_active IP Right Cessation
- 1991-08-19 RU SU5001452/04A patent/RU2066317C1/ru not_active IP Right Cessation
- 1991-08-20 AU AU82596/91A patent/AU646683B2/en not_active Ceased
- 1991-08-20 EP EP91402269A patent/EP0477049B1/fr not_active Expired - Lifetime
- 1991-08-20 CA CA002166902A patent/CA2166902C/en not_active Expired - Fee Related
- 1991-08-20 ES ES91402269T patent/ES2142798T3/es not_active Expired - Lifetime
- 1991-08-20 CA CA002166903A patent/CA2166903C/en not_active Expired - Fee Related
- 1991-08-20 DK DK91402269T patent/DK0477049T3/da active
- 1991-08-20 ZA ZA916583A patent/ZA916583B/xx unknown
- 1991-08-20 AT AT91402269T patent/ATE187167T1/de not_active IP Right Cessation
- 1991-08-20 NZ NZ239476A patent/NZ239476A/xx not_active IP Right Cessation
- 1991-08-20 CA CA002166901A patent/CA2166901C/en not_active Expired - Fee Related
- 1991-08-20 SG SG1996002749A patent/SG52322A1/en unknown
- 1991-08-20 CA CA002049514A patent/CA2049514C/en not_active Expired - Fee Related
- 1991-08-20 DE DE69131813T patent/DE69131813T2/de not_active Expired - Fee Related
- 1991-08-20 CZ CS912574A patent/CZ281864B6/cs not_active IP Right Cessation
- 1991-08-20 JP JP3208108A patent/JP2694932B2/ja not_active Expired - Fee Related
- 1991-08-20 KR KR1019910014358A patent/KR100223074B1/ko not_active Expired - Fee Related
- 1991-08-20 MY MYPI91001513A patent/MY121908A/en unknown
1992
- 1992-06-26 MX MX9203576A patent/MX9203576A/es unknown
1993
- 1993-02-25 LV LVP-93-138A patent/LV10434B/en unknown
- 1993-06-15 LT LTIP656A patent/LT3520B/lt not_active IP Right Cessation
- 1993-09-13 US US08/119,830 patent/US5420141A/en not_active Expired - Lifetime
1995
- 1995-02-24 US US08/393,829 patent/US5635526A/en not_active Expired - Fee Related
- 1995-02-27 US US08/394,757 patent/US5607958A/en not_active Expired - Fee Related
- 1995-02-27 US US08/394,756 patent/US5616592A/en not_active Expired - Fee Related
- 1995-06-30 HU HU95P/P00632P patent/HU211970A9/hu unknown
1996
- 1996-12-31 US US08/775,150 patent/US5744493A/en not_active Expired - Fee Related
1997
- 1997-01-02 US US08/778,105 patent/US5744491A/en not_active Expired - Fee Related
2000
- 2000-02-23 GR GR20000400431T patent/GR3032732T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU646683B2 (en)	1994-03-03
EP0477049A1 (fr)	1992-03-25
FI104170B1 (fi)	1999-11-30
HUT59106A (en)	1992-04-28
HU912750D0 (en)	1992-01-28
CA2166903C (en)	1998-09-01
PT98717A (pt)	1992-07-31
US5744493A (en)	1998-04-28
NO913234L (no)	1992-02-21
KR100223074B1 (ko)	1999-10-15
CA2166902A1 (en)	1992-02-21
IE912932A1 (en)	1992-02-26
MY121908A (en)	2006-03-31
JP2694932B2 (ja)	1997-12-24
GR3032732T3 (en)	2000-06-30
US5616592A (en)	1997-04-01
CZ281864B6 (cs)	1997-03-12
CA2166901C (en)	1999-01-26
IL99225A0 (en)	1992-07-15
HK1005136A1 (en)	1998-12-24
LV10434B (en)	1995-10-20
DK0477049T3 (da)	2000-04-25
US5744491A (en)	1998-04-28
NZ239476A (en)	1993-11-25
KR920004354A (ko)	1992-03-27
TW366337B (en)	1999-08-11
PL169085B1 (pl)	1996-05-31
CA2166901A1 (en)	1992-02-21
RU2066317C1 (ru)	1996-09-10
US5635526A (en)	1997-06-03
ES2142798T3 (es)	2000-05-01
SG52322A1 (en)	1998-09-28
CA2049514C (en)	1997-02-25
NO913234D0 (no)	1991-08-19
FI913917A7 (fi)	1992-02-21
HU211970A9 (en)	1996-01-29
DE69131813T2 (de)	2000-05-31
FR2665898B1 (fr)	1994-03-11
MX9203576A (es)	1992-07-01
PT98717B (pt)	1999-01-29
LT3520B (en)	1995-11-27
CA2166902C (en)	1999-01-19
CS257491A3 (en)	1992-06-17
FI913917A0 (fi)	1991-08-19
LTIP656A (en)	1995-01-31
CA2166903A1 (en)	1992-02-21
ZA916583B (en)	1992-05-27
FI104170B (fi)	1999-11-30
FR2665898A1 (fr)	1992-02-21
EP0477049B1 (fr)	1999-12-01
NO300212B1 (no)	1997-04-28
US5420141A (en)	1995-05-30
JPH04244065A (ja)	1992-09-01
PL291463A1 (en)	1992-07-13
LV10434A (lv)	1995-02-20
ATE187167T1 (de)	1999-12-15
IL99225A (en)	1995-10-31
AU8259691A (en)	1992-02-27
AR248133A1 (es)	1995-06-30
DE69131813D1 (de)	2000-01-05
US5607958A (en)	1997-03-04
HU217435B (hu)	2000-01-28
CA2049514A1 (en)	1992-02-21

Publication	Publication Date	Title
BR9103550A (pt)	1992-04-07	Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica
BR9503638A (pt)	1996-05-28	Composto processo para sua produção e formulação farmacêutica
BR9004852A (pt)	1991-09-10	Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica
BR8905072A (pt)	1990-05-08	Mistura,processo para sua obtencao e folhas
BR9505940A (pt)	1997-12-23	Comprimido mastigável e processo para sua preparação
BR9200951A (pt)	1992-11-17	Compostos, processo para sua producao,preparacoes farmaceuticas e uso
BR9103195A (pt)	1992-05-05	Composto e processo para sua preparacao
BR9204441A (pt)	1993-06-01	Polimero,processo para sua preparacao e composicao elastomerica
BR9000116A (pt)	1991-10-08	Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao
BR8905837A (pt)	1990-06-12	Composto,processo para sua preparacao e composicao fotocuravel
BR9101121A (pt)	1991-11-05	Composto,processo para sua preparacao,suas aplicacoes,e preparado farmaceutico
BR9206950A (pt)	1995-11-28	Composição farmacêutica e processo para sua preparação
BR8902306A (pt)	1990-01-09	Composicao e processo para sua preparacao
BR9004194A (pt)	1991-09-03	Poliisocianatos,misturas,processo para sua preparacao e emprego
BR9506106A (pt)	1997-12-23	Composto processo para sua preparação medicamento e composição farmacêutica
BR9303456A (pt)	1994-03-22	Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego
BR9200697A (pt)	1992-11-10	Oxido de zirconio monoclino,processo para sua preparacao e sua aplicacao
BR1100524A (pt)	2000-03-14	Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
BR9204547A (pt)	1993-06-01	Hidroxipiridoncarboxamidas,processo de sua preparacao e aplicacao
BR8502707A (pt)	1986-05-27	1,3-oxazolidina-2-ona derivados e processo para sua preparacao
BR9301448A (pt)	1993-10-13	Composicao e processo para sua preparacao
MX9102630A (es)	1992-06-01	Derivados de benzamida y proceso para su preparacion.
BR8904468A (pt)	1990-04-17	Composicao,processo para a preparacao de produtos e aplicacao
BR9102229A (pt)	1992-01-07	Compostos e processo para a sua producao,composicao odorizante e uso dos ditos compostos
BR9401490A (pt)	1994-10-18	Composição de xampu e processo para sua produção

Legal Events

Date	Code	Title	Description
1997-11-18	FA	Application withdrawn